37,650 paid endpoints are listed. 23,105 answered a real 402 at the last check.
Every x402 endpoint on the Coinbase Bazaar and x402scan, probed unpaid every six hours. A listing tells you the price a seller wrote down. This tells you whether the endpoint is reachable, whether it charges what it declared, and how fast it answers. Ranked by an assay score out of 100.
Last check 2026-09-30 12:50 UTC · 37,650 probed
ScoreEndpointPrice · networkLatencyPayers 30dUptimeLast 30 probes
- 75api.magentlab.com/api/calc/up_to_7Mazzaferro 2009 Up-to-seven: meets_up_to_seven is true iff tumor_count plus largest_cm is 7 or less and microvascular_invasion is false. Returns the boolean and size_number_sum, not a 5-year survival percentage. Pathology/explant-style inputs as assigned by the caller; magent does not interpret imaging or histology. Not Milan, not Metroticket 2.0 AFP criteria, not a contour calculator, not a medical device, and not a transplant listing.
$0.005$0.007 Base1676 ms1 payers100% up - 75api.magentlab.com/api/calc/milanMazzaferro 1996 Milan criteria for small HCC in cirrhosis: meets_milan is true iff there is no preoperative vascular invasion, no extrahepatic or lymph-node disease, and either one tumor 5 cm or less or two to three nodules each 3 cm or less. Four or more nodules fail. tumor_count and largest_cm are caller-assigned; magent does not interpret imaging. Not a medical device, not a transplant listing, and not UCSF criteria.
$0.005$0.007 Base1675 ms1 payers100% up - 75api.magentlab.com/api/calc/fongFong 1999 clinical score after hepatic resection for metastatic colorectal cancer: five caller-assigned preoperative flags (node-positive primary, disease-free interval <12 months, more than one hepatic tumor, largest tumor >5 cm, CEA >200 ng/mL), 1 point each, score 0–5. favorable is true iff score ≤2. Not a resectability decision or adjuvant protocol. magent does not interpret imaging or pathology.
$0.005$0.007 Base1203 ms1 payers100% up - 75api.magentlab.com/api/calc/galadJohnson 2014 GALAD linear predictor from age, sex, AFP ng/mL, AFP-L3 percent, and DCP ng/mL. galad_score = -10.08 + 0.09*age + 1.67*sex + 2.34*log10(AFP) + 0.04*AFP-L3 + 1.33*log10(DCP); sex is 1 if male else 0. Returns galad_score to 2 decimals. Not an HCC diagnosis, listing protocol, probability, or Johnson 2015 ALBI. DCP is ng/mL, not mAU/mL.
$0.005$0.007 Base1590 ms1 payers100% up - 75api.magentlab.com/api/calc/r_factorCIOMS R factor from ALT, ALP, and laboratory ULNs (Bénichou 1990). R = (ALT/ALT_ULN)/(ALP/ALP_ULN), rounded to 1 decimal, then hepatocellular (R ≥ 5), cholestatic (R ≤ 2), or mixed (2 < R < 5). Deterministic published arithmetic with citation. Not a medical device, not a DILI diagnosis or RUCAM score; magent does not assay enzymes. R is the enzyme pattern only.
$0.005$0.007 Base1517 ms1 payers100% up - 75api.magentlab.com/api/calc/car_oltVanWagner 2017 CAR-OLT integer points (Table 3) for 1-year CVD complication after first orthotopic liver transplant: age bands, sex, caller-assigned race (white 7, black 10, other 0), work, education, atrial fibrillation 25, ventilator 13, pulmonary hypertension 9, no HCC 6, hypertension 4, diabetes 4, heart failure 7. Table 4 predicted percent. Not a listing decision. magent does not assign race.
$0.005$0.007 Base1520 ms1 payers100% up - 75api.magentlab.com/api/calc/west_havenWest Haven / Conn hepatic encephalopathy grade 0-4 (Conn 1977). Deterministic published grade with citation. Not a diagnosis; magent does not examine the patient or apply ISHEN covert/overt or psychometric minimal-HE tests.
$0.005$0.007 Base1347 ms1 payers100% up - 75api.magentlab.com/api/calc/pfib_cLefere 2025 pFIB-c logistic probability of significant (>=F2) liver fibrosis in pediatric MASLD from sex (boy/girl), hypertension, ALT (U/L), caller-assigned CDC/WHO weight Z-score, HOMA-IR, and caller-assigned Black ethnicity. Table 2 coefficients. Derivation rule-out cutoff 0.226. magent does not assign race or ethnicity and does not compute LMS Z-scores. Not a biopsy, not pFIB-6, and not a diagnosis.
$0.005$0.007 Base1286 ms1 payers100% up - 75api.magentlab.com/api/calc/apriWai 2003 AST to platelet ratio index (APRI) from AST, laboratory AST ULN, and platelet count. Returns APRI to two decimals plus published training-set cut-offs for significant fibrosis (Ishak ≥3) and cirrhosis. ULN is required; magent does not assume 40 U/L. Not a diagnosis, not FIB-4, and not a biopsy.
$0.005$0.007 Base1042 ms1 payers100% up - 75api.magentlab.com/api/calc/vocal_pennMahmud 2021 VOCAL-Penn 30-day postoperative mortality logistic for cirrhosis. log_odds = -5.472096 + 1.061725*ASA + 0.927904*emergency + surgery dummies (laparoscopic abdominal reference) + Stata 3-knot RCS albumin (2.7, 3.7, 4.4) and platelets (75, 152, 271) + 0.1448936*bilirubin - 0.7541669*obesity + 0.8268748*NAFLD. Percent to 1 decimal. Not a surgical order. magent does not assign ASA or read labs.
$0.005$0.007 Base1369 ms1 payers100% up - 75api.magentlab.com/api/calc/child_pughChild–Pugh (Child–Turcotte–Pugh) cirrhosis severity from bilirubin, albumin, INR, caller-assigned encephalopathy, and ascites. Deterministic published score with citation; not a transplant listing protocol.
$0.005$0.007 Base1285 ms1 payers100% up - 75api.magentlab.com/api/calc/maddreyMaddrey discriminant function (1978) from patient and control prothrombin time in seconds plus bilirubin. Deterministic published formula with citation; not a diagnosis or steroid order.
$0.005$0.007 Base1598 ms1 payers100% up - 75api.magentlab.com/api/calc/psc_revisedKim 2000 revised natural history model for primary sclerosing cholangitis (no histologic stage). R = 0.03*age_years + 0.54*ln(bilirubin_mg_dL) + 0.54*ln(AST_U_L) + 1.24*variceal_bleeding - 0.84*albumin_g_dL. Natural log. Returns R only; does not look up unpublished survival percents or invent risk bands. Not a transplant listing, biopsy order, PSC diagnosis, or lab assay. Not the original Mayo PSC biopsy model.
$0.005$0.007 Base1167 ms1 payers100% up - 75api.magentlab.com/api/calc/meld_3Kim 2021 MELD 3.0 from sex, bilirubin, INR, creatinine, sodium, albumin, and dialysis. meld_3 = round(1.33*(female) + 4.56*ln(bilirubin) + 0.82*(137-Na) - 0.24*(137-Na)*ln(bilirubin) + 9.09*ln(INR) + 11.14*ln(creatinine) + 1.85*(3.5-albumin) - 1.83*(3.5-albumin)*ln(creatinine) + 6). Creatinine 1.0-3.0 (dialysis 3.0); bilirubin and INR floor 1.0; sodium 125-137; albumin 1.5-3.5. Not original MELD or MELD-Na. Not a transplant listing or allocation order.
$0.005$0.007 Base1851 ms1 payers100% up - 75api.magentlab.com/api/calc/kim_meldnaKim 2008 NEJM MELD-Na from creatinine, bilirubin, INR, sodium, and dialysis. Then-current UNOS MELD: dialysis sets creatinine 4.0 else clamp 1.0-4.0; bilirubin and INR floor 1.0. Sodium bound 125-140. MELDNa = MELD - Na - 0.025*MELD*(140-Na) + 140. Not OPTN 2016 MELD-Na (Na 125-137 only if MELD>11). Not Kim 2021 MELD 3.0. Not a transplant listing or allocation order.
$0.005$0.007 Base1680 ms1 payers100% up - 75api.magentlab.com/api/calc/meld_naCited OPTN/UNOS 2016 MELD-Na score. Agents must not invent MELD-Na from model memory; pay per request with x402 USDC on Base. Deterministic published score with citation. Not a treatment recommendation.
$0.005$0.007 Base1838 ms1 payers100% up - 75api.magentlab.com/api/calc/reach_bYang 2011 REACH-B 17-point HCC risk (non-cirrhotic REVEAL-HBV). Sex female 0, male 2; age 30-65 (30-34 0 through 60-65 6); ALT U/L <15 0, 15-44 1, >=45 2; HBeAg positive 2; HBV DNA copies/mL <10000 0, 10000-99999 3, 100000-999999 5, >=1000000 4. Returns score 0-17 and published 3/5/10-year percents. Not a diagnosis, not a biopsy, not for cirrhosis. magent does not assay ALT or HBV DNA.
$0.005$0.007 Base1087 ms1 payers100% up - 75api.magentlab.com/api/calc/fib4Cited Sterling 2006 FIB-4 fibrosis index. Agents must not invent FIB-4 from model memory; pay per request with x402 USDC on Base. Deterministic published index with citation. Not a treatment recommendation.
$0.005$0.007 Base1595 ms1 payers100% up - 75api.magentlab.com/api/calc/interchestAerts 2017 INTERCHEST: six equally weighted predictors for CAD in primary-care chest pain (age ≥55 male or ≥65 female +1; physician suspected serious +1; history of CAD +1; pain on exertion +1; pressure quality +1; pain reproducible on palpation −1). Range −1 to 5. CAD considered absent iff score <2. Published CAD probability 2.1% (95% CI 1.1–3.9) when <2 and 43.0% (35.8–50.4) when ≥2 in the 13.2% prevalence setting. Not HEART, not EDACS. magent does not examine the chest.
$0.005$0.007 Base1830 ms1 payers100% up - 75api.magentlab.com/api/calc/ccs_anginaCCS angina of effort class 1-4 as assigned by the caller (Campeau 1976 Table 1). Returns class, score, max 4, and the published class description. Class 1-4 only; no class 0. magent does not walk the patient, interpret a treadmill, or examine the patient. Not an ACS diagnosis, not NYHA, and not a silent-ischemia screen.
$0.005$0.007 Base1004 ms1 payers100% up - 75api.magentlab.com/api/calc/mhsMarburg Heart Score (Bösner 2010 Table 3): five 1-point determinants (age/sex, known vascular disease, patient assumes cardiac origin, pain worse with exercise, pain not reproducible by palpation), max 5. Returns the published discrimination cut-off: positive (3-5) or negative (<=2). Primary-care chest-pain rule only; not an ED ACS rule-out, diagnosis, or admission order. magent does not interview the patient.
$0.005$0.007 Base1691 ms1 payers100% up - 75api.magentlab.com/api/calc/orbiAuffret 2018 ORBI integer score for in-hospital cardiogenic shock after STEMI treated by primary PCI. Rounded adjusted-OR points (max 36) from age >70, prior stroke/TIA, cardiac arrest, anterior STEMI, FMC-to-PPCI >90 min, Killip I-III, heart rate >90, SBP <125 with pulse pressure <45, glucose >10 mmol/L, left-main culprit, and post-PPCI TIMI <3. Derivation-cohort class I-IV percents. Not a medical device, not a cath-lab or shock-treatment order, and not the ORBIT bleeding score.
$0.005$0.007 Base1445 ms1 payers100% up - 75api.magentlab.com/api/calc/killipKillip and Kimball 1967 myocardial-infarction heart-failure class 1-4 as assigned by the caller. Returns the published class, description (no heart failure; S3 and basilar rales; pulmonary edema; cardiogenic shock), and 1967 CCU hospital mortality (6%, 17%, 38%, 81%). Not a diagnosis; magent does not examine the patient. Not GRACE or contemporary registry mortality.
$0.005$0.007 Base1036 ms1 payers100% up - 75api.magentlab.com/api/calc/edacsThan 2014 EDACS from age bands, male sex, known CAD or three risk factors (age 18-50 only), diaphoresis, radiation, inspiration (−4), and palpation (−6). Returns the point total (may be negative) and whether the score is <16. The paper ADP also requires ECG and 0/2h troponin, which magent does not take. Not a diagnosis or discharge order. Deterministic published arithmetic with citation.
$0.005$0.007 Base1270 ms1 payers100% up - 75api.magentlab.com/api/calc/modified_sgarbossaSmith 2012 unweighted modified Sgarbossa for STEMI equivalent in LBBB. Positive if ANY of three caller-assigned flags is true: concordant ST elevation ≥1 mm in a lead with positive QRS, concordant ST depression ≥1 mm in V1–V3, or ≥1 mm discordant STE with ST/S ratio ≤ −0.25 (STE ≥25% of the preceding S-wave). Not the original Sgarbossa 1996 5/3/2 points score. Not a 5 mm discordant rule. magent does not measure the ECG. Not a diagnosis.
$0.005$0.007 Base1123 ms1 payers100% up - 75api.magentlab.com/api/calc/sgarbossaSgarbossa 1996 GUSTO-1 criteria for evolving AMI in left bundle-branch block: caller-assigned concordant ST elevation ≥1 mm (5), concordant ST depression ≥1 mm in V1–V3 (3), and discordant ST elevation ≥5 mm (2). Max 10. Score ≥3 had ~90% specificity in the derivation. Deterministic published score with citation; not a diagnosis, not the Smith modification, and magent does not read the tracing.
$0.005$0.007 Base2195 ms1 payers100% up - 75api.magentlab.com/api/calc/timi_risk_indexMorrow InTIME-II TIMI risk index: heart rate × (age/10)^2 / systolic BP, with the five published groups (≤12.5, >12.5–17.5, >17.5–22.5, >22.5–30, >30). Deterministic published arithmetic with citation; not a reperfusion decision.
$0.005$0.007 Base2190 ms1 payers100% up - 75api.magentlab.com/api/calc/he_macsAlghamdi 2019 HE-MACS ACS probability from age, sex, caller-assigned observed sweating, acute ECG ischaemia, right-arm or shoulder radiation, vomiting, hypotension (SBP <100), and current smoking. Table 2 printed coefficients. Returns probability only; four-group ROC thresholds are in that paper's supplement and are not restated here. magent does not interpret ECG or take a history. Not MACS (Body 2014 biomarkers) or T-MACS. Not a diagnosis.
$0.005$0.007 Base1040 ms1 payers100% up - 75api.magentlab.com/api/calc/macsBody 2014 MACS ACS probability from caller-assigned ECG ischaemia, worsening angina, right-arm radiation, vomiting, observed sweating, hypotension (SBP <100), Roche hs-cTnT ng/L, and ELISA H-FABP ng/mL. Table 2 rounded coefficients. Bands p<0.02 very_low, 0.02<=p<0.05 low, 0.05<=p<0.95 moderate, p>=0.95 high. magent does not interpret ECG or assay biomarkers. Not T-MACS, HEART, or EDACS. Not a diagnosis.
$0.005$0.007 Base1027 ms1 payers100% up - 75api.magentlab.com/api/calc/vancouver_chest_painChristenson 2006 Vancouver Chest Pain Rule. early_discharge_eligible is true when the initial ECG is not abnormal, 2-hour troponin is not elevated, there is no prior ACS or nitrate use, and either palpation reproduces pain or age is under 40 without radiation to neck, arm, or jaw. Age 40 is not the age-history path. magent does not interpret ECGs or assay troponin. Not the 2014 age-50 variant. Not a medical device and not a discharge order.
$0.005$0.007 Base2004 ms1 payers100% up - 75api.magentlab.com/api/calc/heart_pathwayMahler 2015 HEART Pathway for emergency chest pain. early_discharge_candidate is true only when the caller-assigned HEART score is 0-3 and both 0-hour and 3-hour troponin flags are not elevated (above the 99th percentile). HEART items are not assigned here. magent does not read an ECG or assay a troponin. Does not order a stress test or angiogram. High-risk features do not mandate a test. Not a medical device and not a diagnosis.
$0.005$0.007 Base1042 ms1 payers100% up - 75api.magentlab.com/api/calc/hearHEAR score for emergency chest pain from age and caller-assigned history, ECG, and risk factors (each 0-2, max 8). No troponin. Smith 2020 very-low-risk group is scores 0 and 1 (MACE ~0.9% in that paper). Deterministic published score with citation; not a diagnosis or discharge protocol. magent does not interpret history, count risk factors, or read an ECG.
$0.005$0.007 Base1119 ms1 payers100% up - 75api.magentlab.com/api/calc/heartHEART score for emergency chest pain from age and caller-assigned history, ECG, risk factors, and troponin (each 0-2, max 10). Bands 0-3, 4-6, and 7-10 from Six 2008. Deterministic published score with citation; not a diagnosis or discharge protocol. magent does not read an ECG.
$0.005$0.007 Base1027 ms1 payers100% up - 75api.magentlab.com/api/calc/timi_ua_nstemiTIMI risk score for unstable angina / NSTEMI from age and six caller-assigned flags. Returns the 0-7 point total and components. Deterministic published score with citation; not an invasive-strategy protocol.
$0.005$0.007 Base1027 ms1 payers100% up - 75api.magentlab.com/api/calc/garfield_afFox 2017 GARFIELD-AF 1-year all-cause mortality, ischaemic stroke/systemic embolism, and major bleed from age, sex, weight, pulse, diastolic BP, comorbidities, smoking, caller-assigned ethnicity (White/Caucasian reference; Hispanic/Latino, Asian, Black/Mixed/Other), oral anticoagulant class (none, NOAC, VKA), carotid occlusive disease, and antiplatelet therapy. Published 1-year equations. magent does not assign race or ethnicity. Not a diagnosis or anticoagulation order.
$0.005$0.007 Base1925 ms1 payers100% up - 75api.magentlab.com/api/calc/chads_65CCS 2014 CHADS-65 algorithm for nonvalvular AF/AFL stroke-prevention discussion. Oral anticoagulant if age ≥65 or CHF, hypertension, diabetes, or prior stroke/TIA. Else aspirin if coronary, aortic, or peripheral arterial disease. Else none. Not CHADS2, not CHA2DS2-VASc, not HAS-BLED, and not an anticoagulation order. magent does not examine the patient.
$0.005$0.007 Base1691 ms1 payers100% up - 75api.magentlab.com/api/calc/hemorr2hagesGage 2006 HEMORR2HAGES (NRAF) AF major-bleed score: prior bleed 2; hepatic or renal, ethanol, malignancy, age >75, reduced platelet count or function, uncontrolled hypertension, anemia, genetic factors, excessive fall risk, and stroke each 1. Max 12. Warfarin major bleed per 100 patient-years: 0→1.9, 1→2.5, 2→5.3, 3→8.4, 4→10.4, ≥5→12.3. Not a medical device. Not a decision to start or stop anticoagulation. Not HAS-BLED, ORBIT, or ATRIA.
$0.005$0.007 Base1194 ms1 payers100% up - 75api.magentlab.com/api/calc/atria_strokeSinger 2013 ATRIA stroke risk score (not Fang 2011 ATRIA bleed). Age x prior stroke Table 3: <65 0/8, 65-74 3/7, 75-84 5/7, >=85 6/9 without/with prior stroke. Plus 1 each: female, diabetes, heart failure, hypertension, proteinuria, eGFR<45 or ESRD. Max 15 (12 without prior stroke). 0-5 low, 6 moderate, 7-15 high. Not a stroke diagnosis or anticoagulation order. Not CHA2DS2-VASc. magent does not assay eGFR or urine.
$0.005$0.007 Base1118 ms1 payers100% up - 75api.magentlab.com/api/calc/has_bledHAS-BLED score from discrete clinical flags. Use for bleeding-risk arithmetic in atrial fibrillation. Deterministic published score with citation.
$0.005$0.007 Base1039 ms1 payers100% up - 75api.magentlab.com/api/calc/cha2ds2_vascCited Lip 2010 CHA2DS2-VASc stroke-risk score. Agents must not invent CHA2DS2-VASc from model memory; pay per request with x402 USDC on Base. Deterministic published score with citation. Not a treatment recommendation.
$0.005$0.007 Base1427 ms1 payers100% up - 75api.magentlab.com/api/calc/dad_ckdMocroft 2015 D:A:D full CKD risk score (Table 2 integer points only): IDU, hepatitis C, age, caller-assigned eGFR >60, sex, nadir CD4, hypertension, prior CVD, and diabetes. Bands low <0, medium 0–4, high ≥5. Not the short score, not the Poisson probability model, not NNTH, and not an ART start order. Race is not an input.
$0.005$0.007 Base1201 ms1 payers100% up - 75api.magentlab.com/api/calc/nrpeRao 2021 natriuretic response prediction equation from caller-assigned eGFR and BSA, serum and urine creatinine, and urine sodium on a spot sample ~2 h after IV loop diuretic. Na_output_mmol = eGFR*(BSA/1.73)*(SerumCr/UrineCr)*60*3.25*(UrineNa/1000). Poor <50 mmol; suboptimal <100 mmol (includes poor); excellent >150 mmol. magent does not compute eGFR or BSA and does not order a diuretic.
$0.005$0.007 Base1517 ms1 payers100% up - 75api.magentlab.com/api/calc/thakarThakar 2005 clinical score for acute renal failure requiring dialysis after open-heart surgery. Points from sex, CHF, LVEF <35%, preoperative IABP, COPD, insulin-requiring diabetes, previous cardiac surgery, emergency surgery, procedure type (CABG / valve / CABG+valve / other), and preoperative creatinine (<1.2 / 1.2 to <2.1 / >=2.1 mg/dL). Returns integer score (max 17) and category 0–2 / 3–5 / 6–8 / 9–13. Not a dialysis order; not AKIN or RIFLE staging.
$0.005$0.007 Base1596 ms1 payers100% up - 75api.magentlab.com/api/calc/mcmahonMcMahon 2013 Table 3 rhabdomyolysis score: age ≤50→0, >50–≤70→1.5, >70–≤80→2.5, >80→3; female 1; Cr <1.4→0, 1.4–2.2→1.5, >2.2→3; Ca <7.5→2; CPK >40000→2; origin not seizure/syncope/exercise/statin/myositis→3; PO4 <4.0→0, 4.0–5.4→1.5, >5.4→3; HCO3 <19→2. Max 19. Caller-supplied labs and origin. Numeric total only; not a dialysis order.
$0.005$0.007 Base2401 ms1 payers100% up - 75api.magentlab.com/api/calc/ckid_u25CKiD U25 eGFR (Pierce 2021) for ages 1-25: age- and sex-dependent K times height in meters over creatinine (mg/dL), or K over cystatin C (mg/L), or the average of both when both markers are given. Height may be cm or inches; creatinine may be mg/dL or µmol/L. Not the Schwartz 2009 bedside 0.413 formula, not a drug dose, and not a CKD stage. Not a medical device.
$0.005$0.007 Base1522 ms1 payers100% up - 75api.magentlab.com/api/calc/psadtPound 1999 PSA doubling time from two rising PSA values: psadt_months = ln(2) x interval_months / ln(psa2_ng_ml / psa1_ng_ml), 1 decimal. PSA each 0.2-10000 ng/mL; psa2 must exceed psa1; interval_months 0.25-120. Reports the Pound split <=10 vs >10 months (exactly 10.0 is <=10). Two-point first-order kinetics only. magent does not measure PSA. Not a medical device.
$0.005$0.007 Base1456 ms1 payers100% up - 75api.magentlab.com/api/calc/prevailArmstrong 2018 PREVAIL Cox linear predictor for overall survival in chemotherapy-naïve metastatic castration-resistant prostate cancer from albumin, ALP versus ULN, bone metastases under 10, hemoglobin, LDH versus ULN, NLR under 2.5, pain 0-1, liver metastases, ln(PSA), months from diagnosis, and enzalutamide versus placebo. Table 1 HRs as ln(HR). Not a 1-/2-/3-year OS percent (no published S0). magent does not read bone scans. Not a dose or treatment order.
$0.005$0.007 Base1914 ms1 payers100% up - 75api.magentlab.com/api/calc/damicoD'Amico 1998 JAMA clinically localized prostate-cancer groups from caller-assigned T (t1c, t2a, t2b, t2c), Gleason 2-10, and PSA ng/mL (0.1-200). Returns low, intermediate, or high. High if T2c or PSA > 20 or Gleason ≥ 8; else intermediate if T2b or Gleason 7 or PSA > 10 and ≤ 20; else low if T1c/T2a and PSA ≤ 10 and Gleason ≤ 6. Not CAPRA. Not NCCN. magent does not assay PSA or assign Gleason. Not a diagnosis. Not a medical device.
$0.005$0.007 Base1439 ms1 payers100% up - 75api.magentlab.com/api/calc/capraCooperberg 2005 UCSF CAPRA preoperative score (Table 1). Caller-assigned PSA (>=2.1-6 0, >6-10 1, >10-20 2, >20-30 3, >30 4), Gleason 1-3/1-3 0, 1-3/4-5 1, primary 4-5 3, clinical T t1/t2 0 or t3a 1, percent positive biopsies <34 0 or >=34 1, age <50 0 or >=50 1. Score 0-10. Table 4 bands 0_1, 2, 3, 4, 5, 6, ge_7 with 5-year RFS 85/81/66/59/60/34/8. Not Kattan. Not D'Amico. Not CAPRA-S. magent does not assay PSA or read biopsies. Not a diagnosis. Not a medical device.
$0.005$0.007 Base1677 ms1 payers100% up - 75api.magentlab.com/api/calc/uissZisman 2002 localized N0M0 UISS for surgically resected unilateral RCC. Caller-assigned 1997 pathological T (t1-t4), Fuhrman 1-4, ECOG 0-4, and n0_m0 true. Returns low_risk (T1, Fuhrman 1-2, ECOG 0), high_risk (T3 with Fuhrman 2-4 and ECOG ≥1, or any T4), or intermediate_risk (every other N0M0 combination). Not 2001 I-V. Not metastatic UISS. Not SSIGN. magent does not assign TNM or read slides. Not a diagnosis. Not a medical device.
$0.005$0.007 Base1182 ms1 payers100% up - 75api.magentlab.com/api/calc/ssignFrank 2002 SSIGN (stage, size, grade, necrosis) for clear cell RCC after radical nephrectomy. 1997 TNM: pT1 0, pT2 1, pT3 2, pT4 0; N0/Nx 0, N1/N2 2; M0 0, M1 4; size ≥5 cm 2; nuclear grade 1–2 0, 3 1, 4 3; coagulative necrosis 2; max 15. Returns the published CSS row. Not 2002/2010 TNM. magent does not stage or read pathology. Not a diagnosis. Not a medical device.
$0.005$0.007 Base1840 ms1 payers100% up - 75api.magentlab.com/api/calc/gleasonGleason 1974 prostatic adenocarcinoma score from caller-assigned primary pattern 1-5 plus secondary pattern 1-5. Score equals primary plus secondary (range 2-10). magent does not read slides. Not ISUP/Epstein 2016 Grade Groups. Not 2005 ISUP modified pattern rules. Not a diagnosis or treatment recommendation. Not a medical device.
$0.005$0.007 Base1680 ms1 payers100% up - 75api.magentlab.com/api/calc/renal_nephrometryKutikov 2009 R.E.N.A.L. nephrometry. Caller-assigned radius le_4 1 / gt_4_lt_7 2 / ge_7 3 (cm); exophytic ge_50 1 / lt_50 2 / entirely_endophytic 3; nearness ge_7 1 / gt_4_lt_7 2 / le_4 3 (mm); location entirely_polar 1 / crosses_polar 2 / gt_50_midline_or_between 3. Anterior a|p|x and hilar suffix h are descriptors, not points. Sum 4-12. No published complexity bands. Not PADUA. Not STONE nephrolithometry. magent does not read CT. Not a medical device. Not a nephrectomy order.
$0.005$0.007 Base1298 ms1 payers100% up - 75api.magentlab.com/api/calc/vurxKirsch 2014 VURx for children <2 years with primary vesicoureteral reflux. Caller-assigned vur_timing (voiding 1, late filling 2, early- or mid-filling 3), female (1), high_grade grade IV-V (1), and ureteral_anomaly (complete duplication or periureteral diverticulum, 1). Score 1-6. Improvement or resolution: 1 → 89%, 2 → 69%, 3 → 53%, 4 → 16%, 5-6 → 11%. magent does not read a VCUG. Not a medical device. Not a surgery order.
$0.005$0.007 Base2076 ms1 payers100% up - 75api.magentlab.com/api/calc/feureaFractional excretion of urea (FEUN) from BUN, urine urea nitrogen, and plasma/urine creatinine (Carvounis 2002). Use when diuretics make FENa unhelpful. Deterministic published formula with citation; not a diagnosis.
$0.005$0.007 Base2271 ms1 payers100% up - 75api.magentlab.com/api/calc/fenaFractional excretion of sodium (FENa) from plasma and urine sodium and creatinine. Espinel 1976 oliguric ARF strata. Deterministic published formula with citation; not a diagnosis.
$0.005$0.007 Base1008 ms1 payers100% up - 75api.magentlab.com/api/calc/rifleRIFLE 2004 (Bellomo Fig. 1) class from baseline and current creatinine in mg/dL and a caller-assigned urine-output category. Class is the worse of the two limbs; persistent ARF >4 weeks is Loss and >3 months is ESRD. magent does not assay creatinine, measure urine, or estimate baseline with MDRD. Not a medical device, not a diagnosis, not AKIN 2007, and not KDIGO 2012.
$0.005$0.007 Base1590 ms1 payers100% up - 75api.magentlab.com/api/calc/irae_nephritisASCO 2018 (Brahmer) irAE nephritis grade from creatinine vs baseline (mg/dL). First-match: 4 if dialysis or life-threatening; 3 if fold >3, creatinine >=4.0, or hospitalization; 2 if fold >2; 1 if fold >=1.5 or delta >=0.3; else 0. ICI action continue (0), consider_hold (1), hold (2), permanently_discontinue (3-4). Not a medical device, not a diagnosis, not KDIGO/AKIN, not a steroid dose; magent does not assay creatinine.
$0.005$0.007 Base1836 ms1 payers100% up - 75api.magentlab.com/api/calc/kdigo_akiKDIGO 2012 Table 2 AKI stage 0-3 from baseline and current creatinine in mg/dL and a caller-assigned urine-output category. Stage is the worse of the two limbs; RRT or a caller pediatric eGFR <35 flag is stage 3. magent does not assay creatinine, measure urine, collect weight, or compute eGFR (no MDRD). Not a medical device, not a diagnosis, not AKIN 2007, and not RIFLE.
$0.005$0.007 Base1517 ms1 payers100% up - 75api.magentlab.com/api/calc/akinAKIN 2007 (Mehta Table 2) stage 0-3 from baseline and current creatinine in mg/dL and a caller-assigned urine-output category. Stage is the worse of the two limbs; RRT is stage 3. magent does not assay creatinine, measure urine, or collect weight. Not a medical device, not a diagnosis, not KDIGO 2012, and not RIFLE.
$0.005$0.007 Base1514 ms1 payers100% up - 75api.magentlab.com/api/calc/igan_predictBarbour 2019 race-free full IgAN model: 5-year risk of 50% eGFR decline or ESKD from age, eGFR, MAP, proteinuria g/day, Oxford MEST, RAS blockade, and immunosuppression at biopsy. Risk = 1 - S0(60)^exp(LP) with eTable 3 coefficients. Caller supplies eGFR; magent does not compute CKD-EPI or score the biopsy. Not the race/ethnicity model. Not KFRE. Not a diagnosis or treatment order. Not a medical device.
$0.005$0.007 Base1941 ms1 payers100% up - 75api.magentlab.com/api/calc/kegfrChen 2013 kinetic eGFR (KeGFR) from two plasma creatinines, hours between them, caller-assigned steady-state creatinine and corresponding eGFR/CrCl, and required max_delta_pcr_mg_dl_day (Chen usual default 1.5). KeGFR = (SSPCr * CrCl / MeanPCr) * (1 - 24*dPCr / (dTime_hours * MaxdPCr/Day)), clamped at 0 when that (1 - ratio) term is negative. Creatinine mg/dL only. Not a CKD-EPI result. Not a dialysis prescription. magent does not compute MDRD or CKD-EPI.
$0.005$0.007 Base1517 ms1 payers100% up - 75api.magentlab.com/api/calc/crcl_cockcroft_gaultCited Cockcroft–Gault creatinine clearance. Agents must not invent CrCl from model memory; pay per request with x402 USDC on Base. Deterministic published formula with citation. Not a treatment recommendation.
$0.005$0.007 Base1507 ms1 payers100% up - 75api.magentlab.com/api/calc/mdrdIDMS 4-variable MDRD eGFR (Levey 2006) from standardized creatinine, adult age, sex, and caller-assigned Black. magent does not assign race. Deterministic published formula with citation; not CKD-EPI 2021 and not a dosing recommendation.
$0.005$0.007 Base2472 ms1 payers100% up - 75api.magentlab.com/api/calc/presetHilder 2017 PRESET-Score: five Table 4 items (MAP mm Hg, lactate mmol/L, arterial pH, platelets k/uL, hospital days pre-ECMO) summed 0-15. Returns class I (0-5, 26% ICU mortality), II (6-9, 68%), or III (10-15, 93%) from the derivation cohort. Deterministic published arithmetic with citation; not a cannulation order; magent does not assay labs. Not RESP or SAVE.
$0.005$0.007 Base1840 ms1 payers100% up - 75api.magentlab.com/api/calc/respSchmidt 2014 RESP Table 3 (-22 to 15): age 18-49 0, 50-59 -2, >=60 -3; immunocompromised -2; MV lt_48h +3, h48_to_7d +1, gt_7d 0; one diagnosis (viral/bacterial pneumonia +3, asthma +11, trauma_burn +3, aspiration_pneumonitis +5, other acute +1, nonrespiratory 0); CNS -7; nonpulmonary infection -3; NMB +1; NO -1; bicarbonate -2; arrest -2; PaCO2 >=75 -1; PIP >=42 -1. Class I >=6 92%, II 3-5 76%, III -1 to 2 57%, IV -5 to -2 33%, V <=-6 18%. Not an ECMO order.
$0.005$0.007 Base2581 ms1 payers100% up - 75api.magentlab.com/api/calc/cstatStatic respiratory-system compliance (Cstat) as in ARDS Network 2000 methods: Cstat (mL/cm H2O) = tidal_volume_ml / (pplat_cm_h2o - peep_cm_h2o). Caller supplies the three measured terms. Rejects Pplat less than or equal to PEEP. Does not invent ARDS severity bands from Cstat (Murray 1988 compliance bands are a different tool). Not a ventilator order or medical device. magent does not read the ventilator.
$0.005$0.007 Base2470 ms1 payers100% up - 75api.magentlab.com/api/calc/rothChorin 2016 Roth score: caller max_count (integer 1-30, highest number reached counting 1 to 30 in one breath) and counting_time_seconds (greater than 0, at most 60). Echoes both; time to 1 decimal. Flags quote Table 2/discussion: max_count <10, counting_time <7 s, max_count <7, counting_time <5 s. Not a hypoxia class or 2021 general-practice cutoff. Not a medical device. magent does not time the patient.
$0.005$0.007 Base1684 ms1 payers100% up - 75api.magentlab.com/api/calc/reveal_pahBenza 2019 REVEAL 2.0: start at 6; add published points for etiology (CTD +1, PoPH +3, heritable +2), male >60, renal insufficiency, WHO FC, 6-month hospitalization, SBP <110, HR >96, 6MWD, BNP/NT-proBNP, pericardial effusion, DLCO <40%, mRAP >20, and PVR <5. Returns low (0-6), intermediate (7-8), or high (>=9) 12-month mortality. Caller-assigned; not a PAH diagnosis or dose. Not REVEAL 1.0 or Lite 2.
$0.005$0.007 Base1778 ms1 payers100% up - 75api.magentlab.com/api/calc/irae_pneumonitisBrahmer 2018 ASCO Table 3.1 irAE pneumonitis. First-match: G4 life-threatening respiratory compromise; else G3 hospitalization, oxygen, limiting self-care, or all lobes/>50%; else G2 symptomatic, >1 lobe, 25-50% parenchyma, or limiting instrumental ADL; else G1. ICPi: hold_if_radiographic_progression (G1), hold (G2), permanently_discontinue (G3-4). Caller-assigned flags. magent does not read CT or pulse oximetry. Not SITC 2021, not a CTCAE instrument, not a diagnosis, not a steroid dose.
$0.005$0.007 Base1363 ms1 payers100% up - 75api.magentlab.com/api/calc/radsOh 2012 radiologist's score (RADS) on one 1-cm axial chest CT slice. Four quadrants (not eight). Each quadrant worst finding: normal 0, interstitial 1, ground_glass 2, consolidation 3. Score 0-12; high when score > 8. Caller-assigned findings only; magent does not interpret CT. Not a diagnosis of inhalation injury. Not a bronchoscopy substitute. Not Endorf AIS inhalation grade. Not Yamamura bronchial wall thickness.
$0.005$0.007 Base1079 ms1 payers100% up - 75api.magentlab.com/api/calc/rdosCampbell 2010 RDOS for patients unable to self-report dyspnea. Eight caller-assigned 0-2 integers (heart_rate, respiratory_rate, restlessness, paradoxical_breathing, accessory_muscle_use, grunting, nasal_flaring, look_of_fear). magent sums only (max 16); does not convert raw heart or respiratory rate or observe the patient. Campbell 2010 published the 0-16 instrument; magent does not apply later cutoff papers. Not a medical device and not an opioid or oxygen order.
$0.005$0.007 Base1375 ms1 payers100% up - 75api.magentlab.com/api/calc/ardsnet_tvARDS Network 2000 predicted body weight (PBW) from height and sex, and the lower-tidal-volume arm 6 mL/kg PBW. Male PBW_kg = 50 + 0.91*(height_cm-152.4); female uses 45.5. Also returns the published 4 mL/kg minimum. Height in cm or inches. Not a ventilator order, plateau-pressure titration, Berlin/AECC diagnosis, pediatric tube size, or ETT insertion depth. Not Devine IBW. Deterministic published arithmetic with citation.
$0.005$0.007 Base1275 ms1 payers100% up - 75api.magentlab.com/api/calc/rseBateman 2015 Risk Score for Exacerbations (RSE): Table II normalized points from BMI >=30 (14), ACQ-5 (<1.5=0; 1.5 to <2.5=7; >=2.5=13), FEV1 % predicted (>=90=0; 80 to <90=13; <80=20), daily rescue occasions (<2=0; 2 to <4=11; >=4=26), and GINA step (3=0; 4=27). Total 0-100. Caller-assigned; magent does not administer ACQ-5 or spirometry. Not a diagnosis, GINA step change, or inhaler order.
$0.005$0.007 Base1283 ms1 payers100% up - 75api.magentlab.com/api/calc/passGorelick 2004 three-item Pediatric Asthma Severity Score (PASS): caller-assigned wheezing (0 none or mild; 1 moderate; 2 severe or absent from poor air exchange), work_of_breathing (0 none or mild; 1 moderate; 2 severe), and prolongation_of_expiration (0 normal or mildly prolonged; 1 moderately; 2 severely). magent sums only (max 6) and does not auscultate. Score only; no invented severity or GINA bands. Not a diagnosis, not Chalut 2000 PRAM, not Westley 1978 croup, and not hospital PAS.
$0.005$0.007 Base1245 ms1 payers100% up - 75api.magentlab.com/api/calc/parsBiagini Myers 2019 Pediatric Asthma Risk Score (PARS). Table III weights (OR rounded to nearest integer): parental asthma 2, eczema before age 3 2, wheezing apart from colds 3, wheezing before age 3 3, caller-assigned African American race 2, SPT ≥2 aeroallergens and/or food allergens 2. Max 14. Fig E1 predicted asthma by age 7 as an integer percent. Scores 1 and 13 are unattainable. Not API or mAPI. Not a diagnosis. magent does not assign race and does not perform SPT.
$0.005$0.007 Base1319 ms1 payers100% up - 75api.magentlab.com/api/calc/piamaCaudri 2009 PIAMA Table III decimal clinical prediction score (max 55.1). Male 4.6, post-term 7.3, medium/low parental education 4.2, parental inhaled medication 7.7, wheezing none/1–3/≥4 → 0/4.2/9.1, wheeze or dyspnea apart from colds 7.1, serious infections none/1–2/≥3 → 0/4.6/6.9, eczema with rash 8.2. Score <10 ~3% asthma at 7–8 years; ≥30 ~42%. Not a 0–18 integer port, API, or mAPI. Not a diagnosis. magent does not examine the child.
$0.005$0.007 Base1334 ms1 payers100% up - 75api.magentlab.com/api/calc/mapiGuilbert 2004 mAPI (PEAK Table I). Positive if 4+ wheeze episodes in one year (one MD-diagnosed) plus 1+ major or 2+ minor. Majors: parental asthma, MD atopic dermatitis, aeroallergen sensitization. Minors: milk/egg/peanut sensitization, wheezing unrelated to colds, eosinophils ≥4%. Not original API. Not m²API. Not an asthma diagnosis. magent does not examine the child. Not a medical device.
$0.005$0.007 Base1251 ms1 payers100% up - 75api.magentlab.com/api/calc/pediatric_asthma_scoreQureshi 1998 pediatric asthma score: five caller-assigned 1-3 domains — respiratory_rate (Table 1 age-banded ordinal, not raw breaths/min), oxygen_saturation, auscultation, retractions, and dyspnea. magent sums only (5-15) and returns Table 1 asthma_band mild 5-7, moderate 8-11, or severe 12-15. magent does not count breaths, measure SpO2, auscultate, or grade work of breathing. Not a diagnosis or treatment order. Not PRAM. Not Liu 2004. Not Westley croup.
$0.005$0.007 Base1436 ms1 payers100% up - 75api.magentlab.com/api/calc/liu_respiratoryLiu 2004 respiratory clinical score: four caller-assigned 0-3 domains — respiratory_rate (age-banded Table 1 ordinal, not raw breaths/min), retractions, dyspnea, and auscultation. magent sums only (max 12) and does not count breaths or auscultate. Score only; Liu 2004 does not print mild/moderate/severe total-score cutoffs. Not a diagnosis or treatment order. Not PRAM. Not Westley 1978 croup.
$0.005$0.007 Base1520 ms1 payers100% up - 75api.magentlab.com/api/calc/gold_copdGOLD 2017 spirometric grade (Vogelmeier executive summary). Post-bronchodilator FEV1/FVC < 0.70 defines obstruction; then GOLD 1 if FEV1 % predicted >= 80, GOLD 2 if 50 to <80, GOLD 3 if 30 to <50, GOLD 4 if <30. Ratio >= 0.70 returns not_obstructed even when FEV1 is low. Not GOLD ABE (no mMRC, CAT, or exacerbations). magent does not perform spirometry. Not a medical device or a diagnosis.
$0.005$0.007 Base1241 ms1 payers100% up - 75api.magentlab.com/api/calc/qcsiHaimovich 2020 qCSI (Table 2 bedside points): RR ≤22 → 0, 23–28 → 1, >28 → 2; SpO2 >92 → 0, 89–92 → 2, ≤88 → 5; O2 ≤2 L/min → 0, 3–4 → 4, 5–6 → 5. Max 12. Lowest SpO2 and nasal-cannula flow as assigned by the caller. Not a COVID-19 diagnosis, triage order, or the 12-variable CSI gradient-boosting model. Derivation excluded >6 L/min. magent does not measure vitals.
$0.005$0.007 Base1600 ms1 payers100% up - 75api.magentlab.com/api/calc/nivoHartley 2021 NIVO: consolidation, GCS ≤14, AF, and pH <7.25 score 1 each; time to acidaemia >12 h scores 2; eMRCD 1_to_4 → 0, 5a → 2, 5b → 3 (cannot score both). Returns 0–9 and Table 4 bands 0-2 / 3-4 / 5-6 / 7-9 with grouped in-hospital mortality 5.0 / 16.8 / 41.2 / 71.4%. Not HACOR, DECAF, APACHE II, or a weaning predictor. Not a medical device.
$0.005$0.007 Base1525 ms1 payers100% up - 75api.magentlab.com/api/calc/stop_bangChung 2008 Appendix 2 STOP-Bang OSA screen. Four caller-assigned STOP flags (loud snoring heard through closed doors, daytime tiredness, observed stop-breathing, hypertension) plus computed BANG: BMI >35, age >50, neck >40 cm, male; each 1; max 8. BMI 35, age 50, and neck 40 cm do not score. Returns bands 0-2 and >=3. Not Chung 2012 three-tier, not a medical device, and not a sleep-study order.
$0.005$0.007 Base1525 ms1 payers100% up - 75api.magentlab.com/api/calc/bap_65BAP-65 (Tabak 2009) class I–V for acute exacerbation of COPD. Three caller-assigned main factors: BUN >25 mg/dL, altered mental status (GCS <14 or disoriented/stupor/coma), and pulse >109/min. Age >65 splits class I from II only when zero main factors are present; age is not a fourth additive point. magent does not compute GCS, BUN, or pulse. Not a medical device and not a ventilation or ICU-admission order.
$0.005$0.007 Base1598 ms1 payers100% up - 75api.magentlab.com/api/calc/decafSteer 2012 DECAF: eMRCD 1-4 → 0, 5a → 1, 5b → 2; eosinophils <0.05 ×10^9/L → 1 (0.05 does not score); caller-assigned consolidation → 1; arterial pH <7.30 → 1 (7.30 does not score); atrial fibrillation → 1. Returns a 0–6 total and band 0-1 / 2 / 3-6. Deterministic published points with citation. Not an early-discharge or escalation protocol and not a medical device.
$0.005$0.007 Base1523 ms1 payers100% up - 75api.magentlab.com/api/calc/du_boisdu Bois 2011 abbreviated four-predictor IPF score from age (<60 → 0, 60–69 → 4, ≥70 → 8), 24-week respiratory hospitalization (true → 14), FVC % predicted (<50 → 18, 51–65 → 13, 66–79 → 8, >80 → 0; 50 and 80 unpublished), and 24-week FVC % change (≤ −10 → 21, > −10 and < −4.9 → 10, ≥ −4.9 → 0). Returns a 0–61 total only. Does not interpolate Table 4 risk percents. Not GAP and not a transplant listing.
$0.005$0.007 Base1758 ms1 payers100% up - 75api.magentlab.com/api/calc/catJones 2009 COPD Assessment Test (CAT): eight caller-assigned integers 0-5 (cough, phlegm, chest tightness, breathlessness, activities, confidence, sleep, energy). Sum 0-40. magent does not interview. Jones 2009 printed no GOLD 0-10/11-20/21-30/31-40 impact bands; later website cutoffs are not applied. Not a diagnosis, not GOLD ABE, not BODE, and not a medical device.
$0.005$0.007 Base1519 ms1 payers100% up - 75api.magentlab.com/api/calc/ariscatCanet 2010 ARISCAT simplified risk score (Table 6, β×10 rounded; Mazo 2014 reprints the same points): age <=50=0, 51-80=3, >80=16; SpO2 >=96=0, 91-95=8, <=90=24; respiratory infection last month=17; anemia Hb <=10 flag=11; incision peripheral 0, upper_abdominal 15, intrathoracic 24; duration hours <=2=0, >2 to 3=16, >3=23; emergency=8. Max 123. Low <26, intermediate 26-44, high >=45. Not a diagnosis or cancel-surgery order. magent does not measure SpO2.
$0.005$0.007 Base1008 ms1 payers100% up - 75api.magentlab.com/api/calc/mayo_spnSwensen 1997 Mayo Clinic logistic probability of malignancy for a 4-30 mm radiologically indeterminate solitary pulmonary nodule. Inputs: age, current or former smoking, extrathoracic cancer diagnosed ≥5 years before the nodule, largest diameter in mm, caller-assigned spiculation, and caller-assigned upper-lobe location. Returns logit x and P = e^x / (1 + e^x). magent does not read the film. Not Gould 2007, not Brock, not a diagnosis, not a biopsy order, and not a medical device.
$0.005$0.007 Base1321 ms1 payers100% up - 75api.magentlab.com/api/calc/promisePsallidas 2018 Table 2A clinical PROMISE for malignant pleural effusion: chemo 0/4, radiotherapy 0/2, haemoglobin g/dL 0-4, WBC 10^9/L 0/2/4/7/10, CRP mg/L 0/3/5/8/11, ECOG 0-1=0 or 2-4=7, cancer mesothelioma 0 / other 4 / lung 5. Groups A 0-20 <25%, B 21-27, C 28-35, D >35 >=75% 3-month mortality. Not TIMP1. Not a treatment order.
$0.005$0.007 Base1146 ms1 payers100% up - 75api.magentlab.com/api/calc/lentClive 2014 LENT score for malignant pleural effusion: pleural LDH IU/L (<1500 → 0, >1500 → 1), ECOG 0-4 (0→0, 1→1, 2→2, 3-4→3), serum NLR as a number (<9 → 0, >9 → 1), tumour type (mesothelioma/haematological 0; breast/gynaecological/renal_cell 1; lung/other 2). Score 0-7: 0-1 low, 2-4 moderate, 5-7 high. Equality at 1500 or 9 is not scored. Not a diagnosis or treatment order.
$0.005$0.007 Base1157 ms1 payers100% up - 75api.magentlab.com/api/calc/lightsLight 1972 pleural fluid criteria: exudate if protein ratio > 0.5, LDH ratio > 0.6, or pleural LDH > two-thirds the laboratory LDH ULN. ULN is required; magent does not assume 200 U/L. Strictly greater than those cutoffs. Deterministic published arithmetic with citation; not a diagnosis of cause, not Heffner's abbreviated criteria, and not a chest x-ray interpretation.
$0.005$0.007 Base1163 ms1 payers100% up - 75api.magentlab.com/api/calc/bliPizov 1999 blast lung injury severity. Mild, moderate, or severe only when inputs match a published definition: mild PaO2/FiO2 > 200, localized infiltrates, no pneumothorax; moderate 60 to 200, diffuse infiltrates, with or without pneumothorax; severe < 60, bilateral infiltrates, and bronchopleural fistula. Unmatched combinations are rejected. Caller assigns all findings. magent does not read a chest radiograph or assay blood gas. Not a ventilator prescription.
$0.005$0.007 Base1037 ms1 payers100% up - 75api.magentlab.com/api/calc/hfa_icos_raf_mekLyon 2020 HFA-ICOS baseline CV risk before combination RAF and MEK inhibitors. Very high if heart failure or cardiomyopathy; High if MI/CABG, stable angina, severe valvular disease, prior anthracycline, or ≥5 medium points; Medium if 2-4 medium points; Low if 0-1. Age ≥65 is Medium 1 only. LVEF 50-54 is Medium 2; this table has no printed LVEF <50 High row. Expert-opinion cardiotoxicity guide <2% / 2-9% / 10-19% / ≥20%. Not a treatment order.
$0.005$0.007 Base1071 ms1 payers100% up - 75api.magentlab.com/api/calc/shfmLevy 2006 Seattle Heart Failure Model 1-, 2-, and 3-year survival from Table 2 multivariate HRs. Score = sum of ln(HR)*x; S(t)=exp(-0.0405*t)**exp(score). Age, sex, NYHA, EF, ischemic etiology, SBP, furosemide-eq diuretic, labs, and already-on ACEI, beta-blocker, ARB, K-sparing diuretic, statin, BiV, ICD, or BiV-ICD. Caller assigns class, etiology, and therapy. magent does not measure labs or blood pressure. Not a diagnosis, prescription, or device order.
$0.005$0.007 Base1365 ms1 payers100% up - 75api.magentlab.com/api/calc/pcp_hfKhan 2019 PCP-HF 10-year incident heart-failure percent for age 30-79 from sex, caller-assigned white or black cohort, treated or untreated systolic BP and fasting glucose, total and HDL cholesterol, BMI, smoking, and QRS duration. Table 2 coefficients. Caller assigns cohort; magent does not assign race. Not PREVENT 2024, not 2013 PCE, not a diagnosis or treatment order. magent does not assay lipids, measure blood pressure, or interpret an ECG.
$0.005$0.007 Base1154 ms1 payers100% up - 75api.magentlab.com/api/calc/gwtg_hfPeterson 2010 GWTG-HF Figure 2 integer points for in-hospital mortality in hospitalized heart failure: age 0-28, systolic BP 0-28, BUN 0-28, sodium 0-4, heart rate 0-8, COPD +2, caller-assigned nonblack (black=false) +3. Total 0-100. magent does not assign race. Not a diagnosis.
$0.005$0.007 Base1015 ms1 payers100% up - 75api.magentlab.com/api/calc/euromacs_rhfSoliman 2018 EUROMACS 9.5-point right-sided heart failure score after continuous-flow LVAD. Five caller-assigned flags: RA/PCWP >0.54 (2), hemoglobin ≤10 g/dL (1), multiple IV inotropes (2.5), INTERMACS class 1-3 (2), severe RV dysfunction (2). Max 9.5; half-points not integer-rounded. Bands: low 0-2, intermediate >2 to 4, high >4. Not a device indication. Not Michigan RV-failure score. Not CRITT. magent does not catheterize or echo.
$0.005$0.007 Base1156 ms1 payers100% up - 75api.magentlab.com/api/calc/acc_aha_hf2013 ACCF/AHA heart-failure stages (Yancy) from four caller flags: high risk for HF, structural heart disease, prior or current HF symptoms, and refractory specialized care. Returns hf_stage A, B, C, D, or not_staged. Progressive and inviolate: D first, then C, B, A, else not_staged. Not NYHA class and not a diagnosis. magent does not examine the patient or read an echocardiogram.
$0.005$0.007 Base1166 ms1 payers100% up